Efficacy and Safety Study of Ozanimod in Ulcerative Colitis
Public ClinicalTrials.gov record NCT01647516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Study identification
- NCT ID
- NCT01647516
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Celgene
- Industry
- Enrollment
- 199 participants
Conditions and interventions
Conditions
Interventions
- Ozanimod Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 73 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 25, 2012
- Primary completion
- Mar 9, 2015
- Completion
- Aug 29, 2019
- Last update posted
- May 18, 2021
2012 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials | Anaheim | California | 92801 | — |
| University of California San Diego | La Jolla | California | 92037 | — |
| Alliance Clinical Research | Oceanside | California | 92056 | — |
| Atlanta Gastroenterology Associates, LLC | Atlanta | Georgia | 30342 | — |
| Chevy Chase Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Endoscopic Microsurgery Associates | Towson | Maryland | 21204 | — |
| Clinical Research Institute of Michigan, LLC | Chesterfield | Michigan | 48047 | — |
| Long Island Clinical Research Associates | Great Neck | New York | 11021 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| Consultants for Clinical Research | Cincinnati | Ohio | 45219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01647516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2021 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01647516 live on ClinicalTrials.gov.